GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Enzo Biochem Inc.
Enzo Biochem is a biotech company that has undergone a complex transformation. Its price chart reflects the sale of its clinical laboratory and efforts to focus on the development and sale of diagnostic products.
Share prices of companies in the market segment - Medanalysis
Enzo Biochem is a biotechnology company that develops, manufactures, and markets diagnostic tests and reagents for clinical laboratories. We've classified it as a "Medanalysis" company. The chart below shows how the market values companies operating in the molecular diagnostics field.
Broad Market Index - GURU.Markets
Enzo Biochem is a biotech company that develops and manufactures diagnostic tests and reagents for laboratories. Its scientific advancements make it a prominent player in the GURU.Markets index. The chart below represents the entire market. Find out how Enzo shares compare to the overall market.
Change in the price of a company, segment, and market as a whole per day
ENZ - Daily change in the company's share price Enzo Biochem Inc.
The daily price change of Enzo Biochem, Inc. reflects volatility in the life sciences and diagnostics sector. This indicator demonstrates sensitivity to demand for its products and services from laboratories and clinics.
Daily change in the price of a set of shares in a market segment - Medanalysis
Enzo Biochem is a biotechnology company focused on clinical diagnostics and therapeutic drug development. This diversified business has its own unique dynamics. The chart below illustrates the volatility of the life sciences sector, which helps evaluate ENZ.
Daily change in the price of a broad market stock, index - GURU.Markets
Enzo Biochem is a biotechnology company with diversified businesses in diagnostics and research. Its stock price reflects the combined impact of these businesses and contributes uniquely to the complex landscape of overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Enzo Biochem Inc.
Enzo Biochem, Inc.'s year-over-year performance tells the story of its strategic transformation. Its market capitalization over the past 12 months reflects its decision to sell its clinical laboratories and focus on the production and sale of reagents and diagnostic products, a fundamental shift in its business model.
Annual dynamics of market capitalization of the market segment - Medanalysis
Enzo Biochem, Inc. is a diversified life sciences company with operations in both diagnostics and reagent manufacturing. This chart illustrates how its complex structure, restructuring efforts, and competition in these segments impact its performance within the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Enzo Biochem, a veteran in the diagnostics industry, tells the story of its transformation and search for a new strategy through its dynamic performance. Its performance, compared to the market, reflects the company's efforts to monetize its assets and find a profitable niche in the competitive world of medical testing.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Enzo Biochem Inc.
Enzo Biochem is a diversified biotechnology company. Its monthly performance reflects its transition from a clinical laboratory model to therapeutic drug development. Key news includes asset sales and R&D progress.
Monthly dynamics of market capitalization of the market segment - Medanalysis
Enzo Biochem is a biotech company operating in two segments: clinical laboratories and diagnostic platform development. Its performance reflects both the state of the laboratory services market and investor confidence in its scientific developments. The sector chart shows the general trends against which Enzo is attempting to compete and innovate.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Enzo Biochem, Inc. is an integrated life sciences company operating in both clinical laboratories and research products. Its business is diversified yet competitive. A broad market chart allows you to assess how its complex transformation and competition in diagnostics have impacted its stock.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Enzo Biochem Inc.
Enzo Biochem is a biotechnology company operating in the diagnostics and life sciences sectors. Its weekly stock price is driven by the performance of its clinical laboratory business and reagent sales.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Enzo Biochem is a biotechnology company operating in clinical diagnostics and life sciences. The company is undergoing a transformation, which adds risks. The chart below shows whether Enzo's share price fluctuations are a reaction to its restructuring strategy or reflect broader trends in the diagnostics sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Enzo Biochem is a biotech company. Its shares move on news about clinical trials and corporate events. This chart clearly demonstrates how much its performance is driven by internal events rather than general market trends.
Market capitalization of the company, segment and market as a whole
ENZ - Market capitalization of the company Enzo Biochem Inc.
Enzo Biochem's market capitalization chart tells the story of a company attempting to transform itself from a diagnostic reagent supplier into a full-fledged clinical laboratory. Its market valuation reflects how investors weigh the value of its assets and patents against operating losses and intense competition.
ENZ - Share of the company's market capitalization Enzo Biochem Inc. within the market segment - Medanalysis
Enzo Biochem is a company operating in clinical diagnostics and biomedical research. Its market share in the sector is small, reflecting intense competition. The market capitalization chart shows how the market values its portfolio of diagnostic products and research tools compared to larger players.
Market capitalization of the market segment - Medanalysis
The chart below shows the market capitalization of the medical diagnostics sector. Enzo Biochem is a veteran of the industry, having risen from technology development to managing its own clinical laboratory. Its complex history, compared to the market, exemplifies the difficulty of competing with giants and the importance of constantly adapting your business model.
Market capitalization of all companies included in a broad market index - GURU.Markets
Enzo Biochem is a life sciences company that produces and sells diagnostic tests and reagents. Its market capitalization reflects its position in this market. The chart below shows the economic weight of laboratory reagent manufacturers.
Book value capitalization of the company, segment and market as a whole
ENZ - Book value capitalization of the company Enzo Biochem Inc.
Enzo Biochem's book value is derived from its clinical laboratories and life science reagent production assets. The chart tells the complex story of a company undergoing a process of restructuring and divestiture to focus on its most profitable businesses and stabilize its balance sheet.
ENZ - Share of the company's book capitalization Enzo Biochem Inc. within the market segment - Medanalysis
Enzo Biochem is a biotech company operating in the diagnostics sector. The chart shows its share of tangible assets. These include its clinical laboratories and manufacturing facilities, where tests are developed and manufactured, which are its core business.
Market segment balance sheet capitalization - Medanalysis
Enzo Biochem is a biotechnology company operating in the field of clinical diagnostics. Their business requires certified laboratories equipped with expensive analytical equipment. The book value chart shows the value of this capital-intensive scientific infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
Enzo Biochem's balance sheet includes its large clinical laboratory and reagent and diagnostic manufacturing plants. The chart shows how this vertically integrated resource base has evolved in the life sciences sector.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Enzo Biochem Inc.
Enzo Biochem operates in the field of molecular diagnostics. Its assets include laboratories, patents, and technologies. The chart below shows how the market evaluates the company's scientific and commercial potential. This reflects investors' belief that its diagnostic tests and platforms will be in demand and profitable.
Market to book capitalization ratio in a market segment - Medanalysis
Enzo Biochem is a biotechnology company operating in clinical diagnostics and life sciences. This chart shows how the market values its diversified portfolio, including laboratories, proprietary technologies, and reagent manufacturing, comparing the combined valuation to the book value of these assets.
Market to book capitalization ratio for the market as a whole
Enzo Biochem develops and markets diagnostic tests. The company combines scientific research with manufacturing. This indicator reflects how the market values its patent and technology portfolio relative to the value of its laboratory and production equipment. The award demonstrates confidence in its innovative potential.
Debts of the company, segment and market as a whole
ENZ - Company debts Enzo Biochem Inc.
Enzo Biochem, a biotech company, is undergoing a strategic transformation. Historically focused on clinical laboratories and diagnostics, the company is divesting assets. This chart reflects its financial position during this transition period, as it manages capital to focus on its remaining businesses.
Market segment debts - Medanalysis
Enzo Biochem is a long-established biotech company currently undergoing a transformation, focusing on diagnostic services and products. Business restructuring often requires capital and time. This chart shows how the company's financial position is changing as it undergoes its strategic shift.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Enzo Biochem Inc.
Enzo Biochem is a biotechnology company providing clinical laboratory services and manufacturing reagents. This chart shows its financial structure. For a company operating in multiple segments, it's important that all segments are sufficiently profitable to maintain a healthy balance sheet.
Market segment debt to market segment book capitalization - Medanalysis
Enzo Biochem is a biotechnology company that provides clinical laboratory services and manufactures reagents. This chart shows the company's leverage in the medical diagnostics sector. It helps understand how this diversified company manages its finances across two distinct but related healthcare segments.
Debt to book value of all companies in the market
Enzo Biochem is a biotech company operating in clinical diagnostics. This sector is competitive and requires investment in new tests and technologies. This chart of total market debt helps understand how the company finances its research and development and how its financial policies compare to other diagnostic companies.
P/E of the company, segment and market as a whole
P/E - Enzo Biochem Inc.
Enzo Biochem is a biotechnology company that operates in both clinical laboratory research and the development and production of life science reagents. This chart shows how investors view its hybrid business model and restructuring efforts.
P/E of the market segment - Medanalysis
Enzo Biochem is a life sciences company operating in two segments: a clinical laboratory providing diagnostic services and the production of reagents and platforms for scientific research. This chart shows the average valuation for the medical analysis sector, reflecting how investors value companies with a hybrid model combining services and manufacturing.
P/E of the market as a whole
Enzo Biochem is a biotechnology company providing clinical laboratory services and manufacturing research reagents. The company is undergoing transformation. Its valuation reflects not general market trends, but rather its struggle for survival and ability to successfully restructure its business in a competitive environment.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Enzo Biochem Inc.
Enzo Biochem is a biotechnology company operating in two segments: clinical laboratories and life science reagent development. This chart illustrates future revenue expectations, which depend on diagnostic test volumes and demand for its products from research laboratories and pharmaceutical companies.
%20P%2FE%20Enzo%20Biochem%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Enzo-Biochem-Inc.&v=1772513509403 "Chart of the company's future (projected) P/E Enzo Biochem Inc.")
Future (projected) P/E of the market segment - Medanalysis
Enzo Biochem is a biotechnology company operating in three segments: clinical laboratories, life sciences products, and therapeutics. This chart shows general expectations for the healthcare sector. ENZ's position relative to the average reflects how the market views their diversified yet complex business model and the potential of their therapeutic developments.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772513509415 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
Enzo Biochem is a biotechnology company operating in three segments: clinical laboratory services, reagent development and manufacturing, and therapeutic drug development. This diversified model operates within the life sciences. This graph of overall market expectations provides context for assessing the company's complex and multifaceted business in the healthcare sector.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513509420 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Enzo Biochem Inc.
Enzo Biochem is a biotechnology company operating in two segments: a clinical laboratory providing diagnostic services and the production of reagents for scientific research. Its overall financial performance, shown in the graph, depends on the volume of tests performed in the laboratory and reagent sales to the scientific community.
Profit of companies in the market segment - Medanalysis
Enzo Biochem is an integrated company operating in clinical laboratories, life sciences, and therapeutics. It develops and markets diagnostic tests and reagents. This chart shows overall profitability in the medical testing sector. It illustrates the level of competition and profitability in the diagnostic services market, which depends on testing volume and reimbursement.
Overall market profit
Enzo Biochem is a biotechnology company operating in clinical laboratories, life sciences, and therapeutics. Its performance depends on diagnostic test volumes and reagent sales. Demand for diagnostics is stable, but economic growth, as seen in this chart, could stimulate increased research funding, supporting its life sciences segment.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Enzo Biochem Inc.
Enzo Biochem is a biotechnology company operating in two segments: clinical laboratory services and biomedical research reagents. This chart shows analysts' future earnings expectations, which are a combined assessment of the company's prospects for both segments.
%20profit%20of%20the%20company%20Enzo%20Biochem%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Enzo-Biochem-Inc.&v=1772513509501 "Graph of future (projected) profit of the company Enzo Biochem Inc.")
Future (predicted) profit of companies in the market segment - Medanalysis
Enzo Biochem is a biotechnology company with two distinct businesses: a clinical laboratory that conducts diagnostic tests and the production of reagents for scientific research. This chart shows forecasts for the medical diagnostics sector, helping to assess how Enzo Biochem's diversified model compares to overall trends in healthcare and science.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772513509537 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
Enzo Biochem is a biotechnology company that provides clinical laboratory services and manufactures reagents. Demand for diagnostic tests is relatively stable, but depends on the volume of elective medical procedures, which may decline during periods of economic uncertainty, as predicted by this schedule.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513509562 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Enzo Biochem Inc.
Enzo Biochem is a biotech company operating in both diagnostics and therapeutics. This chart reflects the complex valuation of its diversified business. The dynamics show how the market values both its current diagnostic revenue and the long-term potential of its pharmaceutical developments.
P/S market segment - Medanalysis
Enzo Biochem is a biotechnology company that operates a clinical laboratory and develops and manufactures diagnostic products. Revenue is diversified between services and products. This chart for the medical diagnostics sector helps assess how investors view this hybrid business model and its potential for synergies.
P/S of the market as a whole
Enzo Biochem is a biotechnology company operating in three segments: clinical laboratory, life science reagent manufacturing, and therapeutic drug development. This market revenue valuation chart helps understand how investors view this diversified yet complex business model at the intersection of diagnostics, science, and pharmaceuticals.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Enzo Biochem Inc.
Enzo Biochem is a biotechnology company operating in three segments: clinical laboratories (providing diagnostic services), life sciences (reagents production), and therapeutics (drug development). This chart shows how investors estimate future revenue from its diversified operations, particularly laboratory services.
%20P%2FS%20Enzo%20Biochem%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Enzo-Biochem-Inc.&v=1772513509671 "The graph of the company's future (projected) P/S Enzo Biochem Inc.")
Future (projected) P/S of the market segment - Medanalysis
Enzo Biochem is an integrated life sciences company that operates a clinical laboratory and produces reagents for scientific research. The company's valuation reflects its efforts to restructure and divest assets to focus on more profitable areas, a complex process in the competitive diagnostics environment.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772513509720 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
Enzo Biochem is a biotechnology company that develops, manufactures, and markets diagnostic tests. Demand for its products is driven by healthcare needs. Given the overall forecasts shown in the chart, Enzo Biochem represents an important segment of medical diagnostics.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513509753 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Enzo Biochem Inc.
Enzo Biochem is a life sciences company. This chart shows its revenue, which is generated by two segments: clinical laboratory services (medical testing) and the production and sale of reagents and kits for scientific research and diagnostics.
Sales of companies in the market segment - Medanalysis
Enzo Biochem (ENZ) is an integrated life sciences company. It develops, manufactures, and markets diagnostic products and operates a clinical laboratory. This metric reflects revenue in the medical analytics sector. Enzo Biochem operates at the intersection of science and clinical practice, creating tools for diagnostics and research.
Overall market sales
Enzo Biochem is a biotechnology company that provides clinical laboratory services and manufactures diagnostic reagents. Demand for its laboratory tests depends on overall healthcare spending. This general economic activity influences healthcare funding and insurance coverage, which determines the availability of diagnostic services for patients.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Enzo Biochem Inc.
Enzo Biochem is a biotechnology company operating in two segments: a clinical laboratory providing diagnostic services and the production of reagents for scientific research. Its revenue is driven by test volumes and reagent sales. This chart shows the analysts' combined revenue forecast, reflecting their outlook on both segments.
%20sales%20of%20the%20company%20Enzo%20Biochem%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Enzo-Biochem-Inc.&v=1772513509898 "Schedule of future (projected) sales of the company Enzo Biochem Inc.")
Future (projected) sales of companies in the market segment - Medanalysis
Enzo Biochem is an integrated life sciences company with divisions in diagnostics and reagent manufacturing. This chart segments projected revenue by these two core businesses. This allows us to estimate which part of their business—clinical laboratory or product sales—will be the primary growth driver.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772513509918 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Enzo Biochem is a biotech company with two distinct businesses: clinical laboratories and diagnostic product development. Its operations reflect both the current demand for medical testing and future innovations. This chart highlights general trends in healthcare, and Enzo's financial results demonstrate a balance between a stable service business and risky research.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513509944 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Enzo Biochem Inc.
Enzo Biochem is a biotechnology company with two business lines: a clinical laboratory performing diagnostic tests and the production of reagents for scientific research. Profitability depends on the results of both segments. The graph shows the company's combined ability to generate profits from both medical services and sales of scientific products.
Market segment marginality - Medanalysis
Enzo Biochem is a biotechnology company operating in two segments: clinical laboratory services and the production of reagents for biomedical research. This chart shows the total profitability of its diversified operations. Success depends on the volume of tests performed in the laboratory and reagent sales to the scientific community.
Market marginality as a whole
Enzo Biochem is an integrated life sciences company providing both clinical laboratory services and manufacturing research reagents. This total profitability chart reflects the health of its clients—hospitals and research institutes. Their financial stability determines their diagnostic and research budgets.
Employees in the company, segment and market as a whole
Number of employees in the company Enzo Biochem Inc.
Enzo Biochem is a long-established biotechnology company operating in two segments: clinical laboratory and life sciences product development. This chart reflects the combined workforce involved in both diagnostic services and research reagent production.
Share of the company's employees Enzo Biochem Inc. within the market segment - Medanalysis
Enzo Biochem is an integrated life sciences company focused on both diagnostics and therapeutic development. Its workforce reflects this dual focus. This chart shows the combined human capital involved in both clinical laboratory operations and drug discovery research.
Number of employees in the market segment - Medanalysis
Enzo Biochem is a biotechnology company focused on clinical diagnostics and life sciences. This chart, which shows employment in the medical analytics sector, highlights the growing role of diagnostics in healthcare. For Enzo, the growth in the number of laboratory technicians and scientists indicates increased demand for their reagents, platforms, and clinical laboratory services.
Number of employees in the market as a whole
Enzo Biochem operates in the biotechnology sector, providing diagnostic services and manufacturing research reagents. Demand for its products and services depends on healthcare and research spending. The growth in overall employment, shown in this chart, supports funding for these sectors through taxes and insurance premiums, ensuring stable demand for Enzo.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Enzo Biochem Inc. (ENZ)
Enzo Biochem (ENZ) operates in two segments: clinical laboratories (services, labor-intensive) and R&D/reagent manufacturing (IP, capital-intensive). This metric helps evaluate this hybrid business. It shows how the market weighs their scalable R&D business against their labor-intensive laboratory services, based on total headcount.
%20of%20the%20company%20Enzo%20Biochem%20Inc.%20(ENZ)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Enzo-Biochem-Inc.-ENZ&v=1772513510131 "Chart of market capitalization per employee (in thousands of dollars) of the company Enzo Biochem Inc. (ENZ)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Enzo Biochem is a biotechnology company that provides clinical laboratory services and manufactures reagents. This metric helps evaluate the effectiveness of its hybrid model. It reflects how the market values its technologies and its ability to generate value in both the service and manufacturing segments.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772513510164 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Enzo Biochem is a biotech company operating in both diagnostics (testing and laboratory services) and drug development. This is a diversified model. In this chart, its capitalization per employee reflects the combination of these two areas: labor-intensive laboratory services and potentially high-value developments.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513510209 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Enzo Biochem Inc. (ENZ)
Enzo Biochem is a company with two business lines: clinical laboratory services and diagnostic platform development (R&D). The laboratory business is competitive and low-margin. This chart shows the "mixed" result: how profitable (or unprofitable) the R&D segment balances the operational efficiency of their laboratories.
%20Chart%20Enzo%20Biochem%20Inc.%20(ENZ)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Enzo-Biochem-Inc.-ENZ&v=1772513510237 "Company Profit Per Employee (in thousands of dollars) Chart Enzo Biochem Inc. (ENZ)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Enzo Biochem is a biotechnology company that develops and manufactures diagnostic tests and reagents. In the field of medical diagnostics, the efficiency of laboratory and manufacturing processes is crucial. This metric demonstrates how the company translates scientific research into commercial products, reflecting the productivity of its entire team.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772513510248 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
Enzo Biochem is a life sciences company. They develop and sell diagnostic tests and reagents, as well as operate their own clinical laboratory. This chart, showing average profit per employee across all industries, helps investors assess the high-margin nature of the medical diagnostics and laboratory services sector in terms of per-specialist costs.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513510253 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Enzo Biochem Inc. (ENZ)
Enzo Biochem is an integrated life sciences company providing clinical laboratory services and manufacturing research reagents. Revenue per employee reflects performance across these two segments. The chart shows how the company competes in the diagnostic services market and supplies products for scientific research.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Enzo-Biochem-Inc.-ENZ&v=1772513510257 "Sales chart per company employee Enzo Biochem Inc. (ENZ)")
Sales per employee in the market segment - Medanalysis
Enzo Biochem (ENZ) is a biotechnology company operating in two segments: clinical laboratories (diagnostics) and the development and production of reagents for life sciences. This chart shows the average revenue per employee in this segment. It helps assess how effectively Enzo generates revenue from its laboratory services and products.
Sales per employee for the market as a whole
Enzo Biochem (ENZ) is a company operating at the intersection of life sciences. It operates a clinical laboratory (diagnostics) and develops and manufactures reagents for R&D. This metric reflects the performance of both segments: how productive their laboratory is and how successfully they sell their scientific products per staff of technicians and scientists.
Short shares by company, segment and market as a whole
Shares shorted by company Enzo Biochem Inc. (ENZ)
Enzo Biochem (ENZ) is a life sciences company that underwent a lengthy restructuring, selling its laboratory assets to focus on diagnostics. This chart shows short interest. The high short interest reflects investor skepticism about the success of this transformation, a history of unprofitability, and the highly competitive diagnostics market. (349)
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Enzo-Biochem-Inc.-ENZ&v=1772513510350 "Short Shares Chart for the Company Enzo Biochem Inc. (ENZ)")
Shares shorted by market segment - Medanalysis
Enzo Biochem (ENZ) operates in two segments: clinical laboratory diagnostics and the production of reagents for biomedical research. The chart below shows the overall short position in the medical diagnostics sector. It reflects investors' concerns about pressure on test prices or declining R&D budgets in biotech.
Shares shorted by the overall market
Enzo Biochem is a diagnostics company operating in the competitive laboratory services market. This chart measures general fear. At such times, investors avoid small-cap stocks. They fear that ENZ lacks the scale to compete with the giants and that a recession will cause hospitals to cut back on diagnostics.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Enzo Biochem Inc. (ENZ)
Enzo Biochem is a biotech veteran with two divisions: clinical laboratories and R&D products. This chart shows the "temperature" of their complex business. It "warms up" on news of asset sales or R&D breakthroughs and "cools" due to pricing pressure in the laboratory business.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Enzo-Biochem-Inc.-ENZ&v=1772513510432 "RSI 14 indicator chart for the company's stock Enzo Biochem Inc. (ENZ)")
RSI 14 Market Segment - Medanalysis
Enzo Biochem is a diversified life sciences company. It operates a clinical laboratory and also produces and sells reagents and platforms for scientific research and diagnostics. This chart shows the overall sentiment in the medical diagnostics and analysis sector. It helps understand how investors view the industry and how Enzo compares to its competitors.
RSI 14 for the overall market
Enzo Biochem (ENZ), a diagnostic testing maker, sees a "flight to safety" in this chart. Demand for its products (tests) isn't driven by euphoria or panic—it's driven by patient health. In moments of market panic, investors seek safe havens in stable sectors like healthcare.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ENZ (Enzo Biochem Inc.)
Enzo Biochem operates in two segments: it operates a clinical laboratory (diagnostic services) and produces proprietary reagents and platforms for life sciences R&D. This chart shows the average analyst price target, reflecting their "sum of the parts" valuation of these two businesses and their restructuring efforts.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ENZ-Enzo-Biochem-Inc.&v=1772513510474 "A chart showing analyst consensus forecasts for the expected stock price. ENZ (Enzo Biochem Inc.)")
The difference between the consensus estimate and the actual stock price ENZ (Enzo Biochem Inc.)
Enzo Biochem is a biotech veteran currently focused on clinical laboratory services and diagnostics. This chart shows the difference between the market valuation and the consensus forecast. It reflects whether experts believe they can compete with giants like Quest and LabCorp and the value of their assets.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ENZ-Enzo-Biochem-Inc.&v=1772513510485 "A chart showing the difference between the consensus forecast and the actual stock price. ENZ (Enzo Biochem Inc.)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
Enzo Biochem is a biotech veteran. The company operates a clinical laboratory and develops diagnostic platforms. This chart shows analysts' overall expectations for the entire medical testing sector. It reflects whether experts believe the laboratory business is profitable in a world of cost pressure.
Analysts' consensus forecast for the overall market share price
Enzo Biochem is a biotech veteran. The company has two businesses: diagnostic services (clinical labs) and the production of reagents for scientific research. This chart shows overall market sentiment. For Enzo, which operates in the "defensive" healthcare sector, overall optimism is important, but their business is valued for its stability, as it is less dependent on economic cycles.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Enzo Biochem Inc.
Enzo Biochem is a biotech veteran that has rebooted itself. After selling its COVID-19 diagnostics business, they focused entirely on drug R&D, leveraging their old patents. This chart is a summary indicator of their second chance. It reflects their (very risky) R&D pipeline and their (desperate) race to keep up with the money.
AKIMA Market Segment Index - Medanalysis
Enzo Biochem is a biotech veteran. They operate in two areas: providing clinical laboratory testing (medanalytics) and producing reagents for R&D. They are a hybrid of service and manufacturing. This chart compares their composite index to the sector, showing how their dual model outperforms their competitors.
The AKIM Index for the overall market
Enzo Biochem is a life sciences company producing reagents and kits for research and diagnostics. It sold its clinical laboratory. This chart, reflecting the market average, is a backdrop. It helps assess how ENZ, focused on its food business, compares to general macroeconomic fluctuations.
